Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
Pancreatic cancer (PC) is the fourth leading cause of cancer death, with a median survival of 6 months and a dismal 5-year survival rate of 35%, a figure which has remained relatively unchanged over the past 25 years. PC is one of the most difficult diseases to treat due to late initial diagnosis an...
Saved in:
Main Authors: | Juan Iovanna, José Luis Neira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2010.184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer
by: Perumal Elumalai, et al.
Published: (2014-12-01) -
The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
by: Michalis V. Karamouzis, et al.
Published: (2007-01-01) -
Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
by: A. Manzano, et al.
Published: (2012-01-01) -
Breast Cancer Profile among Patients with a History of Chemoprevention
by: Freya R. Schnabel, et al.
Published: (2016-01-01) -
Biochemical Aspects and Risk Factors Associated with Cervical Cancer
by: Janet Villafuerte Reinante, et al.
Published: (2019-05-01)